Study: C. difficile transmission may hinge on individuals, not infection control tools
By
Kristen Fischer
Sep 19, 2023
A person’s biology may play more of a role in how Clostridioides difficile, or C. diff, spreads more so than healthcare facility preventive measures, a new study finds. This means that transmission of...
Antibiotic overkill leads to widespread side effects such as C. diff, large study finds
By
Alicia Lasek
Apr 02, 2023
“We’re talking about hundreds of thousands of adverse events severe enough that these patients needed additional care from a doctor,” an investigator said.
Dark night of the sole
By
Gary Tetz
Nov 11, 2021
Maybe I just need to stop reading McKnight’s. That’s the bottom line. Because every time I flip through its pages, whether virtually or in print, I seem to discover researchers have found another horrible...
Clinical briefs for Monday, Oct. 5
By
Alicia Lasek
Oct 05, 2020
Blood pressure meds reduce mortality in flu and pneumonia, study finds … Purpose in life linked to fewer dementia-related problems … Poor cognitive performance predicts impaired activities of daily...
Providers credited for 24% drop in C. diff rates
By
Alicia Lasek
Apr 02, 2020
Falling U.S. infection rates are only seen in healthcare settings and are likely due to proactive measures taken by providers, say researchers.
C. diff often originates outside healthcare settings, new study suggests
By
Alicia Lasek
Dec 11, 2019
One in 10 patients admitted to a New York hospital with no C. diff symptoms were found to be carriers. Six months later, 38% had symptoms.
Researchers testing C. diff vaccine in widespread trial
By
Kimberly Marselas
Apr 06, 2015
An international trial is examining the efficacy of a vaccine for C. difficile, the gut-destroying bacterium that is particularly dangerous to seniors.
CDC releases HAI Data: How are we doing?
By
Jacie Volkman, MPH, CIC
Jul 16, 2014
For many years, healthcare institutions have been focused on different ways to decrease HAIs, as federal reimbursement initiatives loomed. So, what does this report card tell us? We’ve come a long...
C. diff vaccine moves closer to reality with launch of large Phase III trial
By
Tim Mullaney
May 19, 2014
A potential Clostridium difficile vaccine performed well in initial tests and now has moved into a large Phase III trial, researchers announced today. The news from developer Sanofi Pasteur raises hopes...
Acute, post-acute partnerships reduce C. diff about 50% in Washington state
By
Tim Mullaney
Mar 25, 2014
Hospitals and post-acute facilities in Washington state have cut their rate of Clostridium difficile infections in half since 2012 by partnering with each other in a robust infection control program, according...